Luoda has a clear commercialisation strategy at the core of its business. This strategy is largely driven by Luoda’s historical association with Bova Compounding, Australia’s largest veterinary compounder.
Luoda has already had significant achievements to date, including three patent applications, an Australian Research Council (ARC) Linkage Grant…
Virtual Pharmaceutical Companies (VPC)
VPCs differ from other R&D and Biotech companies in that they solely comprise experienced teams of managers and consultants who coordinate and monitor
As a virtual pharmaceutical company, Luoda has a core team of experienced pharmacologists and managers who coordinate and monitor on a contractual basis a set of external consultant specialists…
Luoda Pharma (“Luoda“) is an Australian pharmaceutical company that has a particular focus on producing novel animal health products. Luoda has its origins in 2011 when Stephen Page, one of Australia’s pre-eminent veterinary pharmacologists, and Nick Bova, the founder of Bova Compounding, the leading veterinary compounder in Australia, met to discuss how to solve the many unmet treatment issues in veterinary medicine.
Our Track Record
Luoda has already made a number of significant achievements. Luoda has a growing number of patent families protecting its intellectual property globally. Luoda has won a number of competitive Australian research grants supporting the creation of novel products. Despite being such a young company, Luoda has already invented and patented a new animal health product, which has been developed and registered in Australia and is now marketed and sold by a major pharmaceutical company.
The Company is pleased to announce that it submitted the following patents: Provisional Application number 2015905079 – Methods and Compositions for Treating Gastric Ulcers with Esomeprazole (filed 8 December 2015) Provisional Application number 2015905078 – [...]
Luoda is pleased to announce that on 14 December, it signed a partnership with a major animal health company for the research and development of a patented treatment for bovine mastitis. The commercial terms of [...]
Research and Development programmes funded by Luoda have assisted the authors of a new journal article on treatments for Bovine Mastitis: Khazandi, M., P. Eats, D. Trott, E. Ebrahimie, J. Perry, E. Hickey, S. Page, [...]
A study has recently been completed that compared the ease of administration or voluntary acceptance by dogs of the Luoda liquid formulation of pimobendan compared with the currently marketed commercial alternative, which are chewable tablets. 10 dogs [...]
Luoda is pleased to announce that it has raised approximately $1,000,000 in additional capital from over a dozen external investors in Australia and from abroad. The directors believe this gives Luoda enough resources to ambitiously [...]